申请人:BAYER PHARMA AG
公开号:WO2011151259A1
公开(公告)日:2011-12-08
The present invention relates to substituted imidazopyrazine compounds of general formula (I) in which A, R1, R3 and R5 are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, as well as to intermediate compounds useful in the preparation of said compounds.
本发明涉及通式(I)中A、R1、R3和R5如描述和权利要求中所述的取代咪唑吡嗪化合物,以及制备所述化合物的方法,包括含有所述化合物的药物组合物和组合物,以及利用所述化合物制造用于治疗或预防疾病的药物组合物的用途,以及在制备所述化合物中有用的中间化合物。